Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03576508 · ClinicalTrials.gov registry record · Phase 1
A Study to Compare Levels of Capsaicin After Intra-Articular Injection and Topical Application in Patients With Painful Knee Osteoarthritis
A Phase 1 study of Knee Osteoarthritis, sponsored by Centrexion Therapeutics.
- Completed
- Registry status
- Phase 1
- Development phase
- 16
- Enrollment target
- 1
- Study location
NCT03576508 is a Phase 1 study of Knee Osteoarthritis that has completed, run by Centrexion Therapeutics. The registered enrollment target is 16 participants, below the 304-participant average among 101 other Knee Osteoarthritis trials with a reported enrollment target (95% lower). The trial reports 1 study location across 1 state.
The verdict
NCT03576508, a Phase 1 study of Knee Osteoarthritis, has completed, sponsored by Centrexion Therapeutics.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 16 participants
- Enrollment target
- 1
- Study location
Study Summary
This is a Phase 1b, open-label, two-period, randomized crossover study in adult male and female participants with painful knee osteoarthritis.
Conditions Studied
Interventions
- DRUG CNTX-4975-05
- DRUG Qutenza
- DRUG Lidocaine (without epinephrine)
Study Locations (1)
Florida
- Well Pharma Medical Research, Corp - Miami
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 16 participants |
| Start Date | 2018-06-25 |
| Est. Completion | 2018-09-06 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03576508
The ClinicalTrials.gov registry entry for NCT03576508 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 16 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 304-participant average among 101 other Knee Osteoarthritis trials with a reported enrollment target (95% lower). The listed sponsor is Centrexion Therapeutics, which has 12 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Knee Osteoarthritis appearing as the primary indexed condition, and to 3 interventions - of which CNTX-4975-05 is the first listed.
NCT03576508 reports 1 study location spanning 1 distinct geographic area - top geographies include Florida.
Frequently Asked Questions
What is clinical trial NCT03576508 about?
NCT03576508 is a clinical study titled "A Study to Compare Levels of Capsaicin After Intra-Articular Injection and Topical Application in Patients With Painful Knee Osteoarthritis". This is a Phase 1b, open-label, two-period, randomized crossover study in adult male and female participants with painful knee osteoarthritis.
What is the current status of trial NCT03576508?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 16 participants. The study started on 2018-06-25. Estimated completion is 2018-09-06.
What conditions does trial NCT03576508 study?
This clinical trial studies the following conditions: Knee Osteoarthritis.
What interventions are being tested in trial NCT03576508?
The interventions under investigation include: CNTX-4975-05 (DRUG), Qutenza (DRUG), Lidocaine (without epinephrine) (DRUG).
Who is sponsoring clinical trial NCT03576508?
This trial is sponsored by Centrexion Therapeutics, which has 12 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03576508 being conducted?
This trial has 1 study location across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Knee Osteoarthritis
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Optimal Anesthetic for Corticosteroid Injections for Knee Osteoarthritis
RECRUITING · Phase 1
-
Safety and Pharmacodynamics of GNSC-001 Intra-articular Injection for Knee Osteoarthritis
ACTIVE NOT RECRUITING · Phase 1
-
Impact of Mesenchymal Stem Cells in Knee Osteoarthritis
ACTIVE NOT RECRUITING · Phase 1
-
Autologous Alpha-2 Macroglobulin Rich Plasma, Safety and Efficacy in Symptomatic Moderate Knee Osteoarthritis
COMPLETED · Phase 1
-
Comparative Usability Evaluation of Sustained Acoustic Medicine (SAM) Devices and Topical Gel for OA Knee Pain
COMPLETED · Phase 1
-
Catabolic Marker Levels After Platelet Poor Plasma (PPP) Lavage
COMPLETED · Phase 1
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.